Amylyx Pharmaceuticals, Inc.
Pembelian
Diupdate

$AMLX, following the Bio Techs

101
The health care industry is being leading the charge, AMLX is the proof of that. This recent IPO just broke out of a good looking cup & handle pattern. Also, IBD is giving a 99 relative strength rating.

So, I enter today with a small position. A "pilot position", as Mark Minervini would say. The market is still under pressure so I'm testing it.

As this stock is a highly volatile I'll play for a 3:1 risk/reward.

Catatan
Just put my stop loss at breakeven
Catatan
I sold my position at breakeven just be sure. The thing is that the price hasn't break support at its MAs.

I'll keep a close eye on this one for thise week's action.

Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.